100 likes | 253 Views
Based on techniques, the antinuclear antibody test market is segmented into enzyme-linked immunosorbent assay (ELISA), immunofluorescence assay (IFA), and multiplex assay. The ELISA segment is expected to account for the largest share of this market due to the expanding applications of ANA in autoimmune disease testing and therapeutic drug level monitoring.
E N D
MarketsandMarkets Presents Antinuclear Antibody Test Market worth USD 1,476.1 M $ by 2021 http://www.marketsandmarkets.com/Market-Reports/antinuclear-antibody-test-market-218189007.html
The report "Antinuclear Antibody Test Market by Product (Reagents & Assay Kits, Systems, Software, Services), Technique (Immunofluorescence, Elisa, Multiplex), Disease (Rheumatoid Arthritis, SLE), End User (Clinical Labs, Hospitals) - Forecast to 2021", report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the ANA testing market, along with revenue estimates & forecasts and market share analysis. Browse 73 market data Tables and 102 Figures spread through 166 Pages and in-depth TOC on "Antinuclear Antibody Test Market by Product (Reagents & Assay Kits, Systems, Software, Services), Technique (Immunofluorescence, Elisa, Multiplex), Disease (Rheumatoid Arthritis, SLE), End User (Clinical Labs, Hospitals) - Forecast to 2021" http://www.marketsandmarkets.com/Market-Reports/antinuclear-antibody-test-market-218189007.html http://www.marketsandmarkets.com/Market-Reports/antinuclear-antibody-test-market-218189007.html
Early buyers will receive 10% customization on this report. http://www.marketsandmarkets.com/Market-Reports/antinuclear-antibody-test-market-218189007.html
The global antinuclear antibody test market is expected to reach USD 1,476.1 Million by 2021 from USD 823.5 Million in 2016, at a CAGR of 12.4% from 2016 to 2021. The increasing prevalence of autoimmune diseases and increasing healthcare expenditure worldwide are the major factors driving the growth of this market. http://www.marketsandmarkets.com/Market-Reports/antinuclear-antibody-test-market-218189007.html
This report segments this ANA testing market based on products, diseases, techniques, end users, and regions. In the products market, the assay kits & reagents segment is expected to account for the largest share. This segment is also expected to grow at the highest CAGR during the forecast period due to the growth in the number of reagent rental agreements and increasing prevalence of autoimmune diseases worldwide. http://www.marketsandmarkets.com/Market-Reports/antinuclear-antibody-test-market-218189007.html
Based on techniques, the antinuclear antibody test market is segmented into three broad segment, namely, enzyme-linked immunosorbent assay (ELISA), immunofluorescence assay (IFA), and multiplex assay. The ELISA segment is expected to account for the largest share of this market owing to expanding applications of ANA in autoimmune disease testing and therapeutic drug level monitoring. http://www.marketsandmarkets.com/Market-Reports/antinuclear-antibody-test-market-218189007.html
The end-user segments in this market include clinical laboratories, hospitals, POLs, and other end users. The hospitals segment is expected to account for the largest share in 2016, primarily due to the rising healthcare spending which has resulted in a growth in use of ANA testing products in hospitals. Based on region, the global antinuclear antibody test market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period. Growth in this regional segment is driven by factors such as rising geriatric population and increasing prevalence of autoimmune diseases. http://www.marketsandmarkets.com/Market-Reports/antinuclear-antibody-test-market-218189007.html
Key players in the antinuclear antibody test market include Alere Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), ERBA Diagnostics, Inc. (U.S.), Trinity Biotech plc (Ireland), Thermo Fisher Scientific, Inc. (U.S.), Antibodies, Inc. (U.S.), EUROIMMUN AG (Germany), Immuno Concepts (U.S.), Inova Diagnostics (U.S.), and Zeus Scientific, Inc. (U.S.). http://www.marketsandmarkets.com/Market-Reports/antinuclear-antibody-test-market-218189007.html
Contact Us Contact: Mr. Rohan Markets and Markets UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar Pune, Maharashtra 411013, India 1-888-600-6441 Email: sales@marketsandmarkets.com http://www.linkedin.com/company/marketsandmarkets http://www.marketsandmarkets.com/Market-Reports/antinuclear-antibody-test-market-218189007.html
About MarketsandMarkets MarketsandMarkets is the world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. http://www.marketsandmarkets.com/Market-Reports/antinuclear-antibody-test-market-218189007.html